Finlay A McAlister1, Erik Youngson2, Padma Kaul2, Justin A Ezekowitz2. 1. From the Division of General Internal Medicine (F.A.M.), Patient Health Outcomes Research and Clinical Effectiveness Unit (F.A.M., E.Y.), and Division of Cardiology, Mazankowski Alberta Heart Institute (P.K., J.A.E.), University of Alberta, Edmonton, Canada. Finlay.McAlister@ualberta.ca. 2. From the Division of General Internal Medicine (F.A.M.), Patient Health Outcomes Research and Clinical Effectiveness Unit (F.A.M., E.Y.), and Division of Cardiology, Mazankowski Alberta Heart Institute (P.K., J.A.E.), University of Alberta, Edmonton, Canada.
Abstract
BACKGROUND: Although early follow-up for heart failure (HF) is recommended, the time window and which physicians should do the follow-up are unclear. We explored whether (1) follow-up within 14 days and (2) physician continuity influence outcomes within 30 days of a HF exacerbation. METHODS AND RESULTS: Retrospective cohort of all adults in Alberta, Canada, with a first discharge from a hospital or an emergency department where HF was the most responsible diagnosis between April 2002 and November 2013, analyzed using Cox proportional hazards models with time-varying covariates. Of 39 249 adults (mean age,76.1 years), 21 848 (55.7%) received follow-up from a familiar physician, 3938 (10.0%) saw an unfamiliar physician, and 13 463 (34.3%) had no outpatient visits in the first 14 days after a hospitalization or emergency department visit for HF. The risk of death or hospitalization within 30 days was lower in patients who saw a familiar physician (16.9%; adjusted hazard ratio [aHR],0.94;95%confidence interval [CI],0.89-0.99) than inthose who sawan unfamiliar physician (20.0%;aHR,1.05;95%CI,0.97-1.15) or those with no outpatient visits (22.0%;aHR,1.00 [referent]). The composite of death or emergency department visit or hospitalization within 30 days was also less common with familiar physician follow-up (25.2%;aHR,0.86;95%CI,0.82-0.89) compared withunfamiliar physicians (26.9%;aHR,0.93;95%CI,0.87-0.996) or those with no outpatient follow-up within 14 days (47.5%;aHR,1.00 [referent]). CONCLUSIONS: Outpatient follow-up within 14 days after HF exacerbation requiring hospitalization or emergency department visit is associated with better outcomes, particularly if the follow-up is with a familiar physician.
BACKGROUND: Although early follow-up for heart failure (HF) is recommended, the time window and which physicians should do the follow-up are unclear. We explored whether (1) follow-up within 14 days and (2) physician continuity influence outcomes within 30 days of a HF exacerbation. METHODS AND RESULTS: Retrospective cohort of all adults in Alberta, Canada, with a first discharge from a hospital or an emergency department where HF was the most responsible diagnosis between April 2002 and November 2013, analyzed using Cox proportional hazards models with time-varying covariates. Of 39 249 adults (mean age,76.1 years), 21 848 (55.7%) received follow-up from a familiar physician, 3938 (10.0%) saw an unfamiliar physician, and 13 463 (34.3%) had no outpatient visits in the first 14 days after a hospitalization or emergency department visit for HF. The risk of death or hospitalization within 30 days was lower in patients who saw a familiar physician (16.9%; adjusted hazard ratio [aHR],0.94;95%confidence interval [CI],0.89-0.99) than inthose who sawan unfamiliar physician (20.0%;aHR,1.05;95%CI,0.97-1.15) or those with no outpatient visits (22.0%;aHR,1.00 [referent]). The composite of death or emergency department visit or hospitalization within 30 days was also less common with familiar physician follow-up (25.2%;aHR,0.86;95%CI,0.82-0.89) compared withunfamiliar physicians (26.9%;aHR,0.93;95%CI,0.87-0.996) or those with no outpatient follow-up within 14 days (47.5%;aHR,1.00 [referent]). CONCLUSIONS:Outpatient follow-up within 14 days after HF exacerbation requiring hospitalization or emergency department visit is associated with better outcomes, particularly if the follow-up is with a familiar physician.
Authors: Rishi K Wadhera; Karen E Joynt Maddox; Gregg C Fonarow; Xin Zhao; Paul A Heidenreich; Adam D DeVore; Roland A Matsouaka; Adrian F Hernandez; Clyde W Yancy; Deepak L Bhatt Journal: Circ Cardiovasc Qual Outcomes Date: 2018-07
Authors: Austin S Kilaru; Nicholas Illenberger; Zachary F Meisel; Peter W Groeneveld; Manqing Liu; Angira Mondal; Nandita Mitra; Raina M Merchant Journal: Circ Cardiovasc Qual Outcomes Date: 2022-09-08
Authors: Richard Baker; George K Freeman; Jeannie L Haggerty; M John Bankart; Keith H Nockels Journal: Br J Gen Pract Date: 2020-08-27 Impact factor: 5.386
Authors: Hyo Jung Tak; Andrew M Goldsweig; Fernando A Wilson; Andrew W Schram; Milda R Saunders; Michael Hawking; Tanush Gupta; Cindy Yuan; Li-Wu Chen Journal: J Gen Intern Med Date: 2021-05-13 Impact factor: 6.473
Authors: Cinthya Pena Orbea; Hussam Jenad; Lena Lea Kassab; Erik K St Louis; Eric J Olson; Gaja F Shaughnessy; Lillian T Peng; Timothy I Morgenthaler Journal: J Clin Sleep Med Date: 2021-12-01 Impact factor: 4.062
Authors: Leslie L Chang; Haolin Xu; Adam D DeVore; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow; Larry A Allen; Adrian F Hernandez Journal: J Am Heart Assoc Date: 2018-04-01 Impact factor: 5.501